TEV-56248

DRUG2 trials

Sponsors

Teva Branded Pharmaceutical Products R&D LLC, Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

Asthma

Phase 1

Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old

CompletedNCT06290102

Teva Branded Pharmaceutical Products R&D, Inc.Asthma

Start: 2024-05-16End: 2024-10-07Updated: 2025-08-14

Phase 3

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

RecruitingNCT06052267

Teva Branded Pharmaceutical Products R&D LLCAsthma

Start: 2023-08-30End: 2026-10-31Target: 2700Updated: 2026-04-02